Statistical considerations for cross-sectional HIV incidence estimation based on recency test

Stat Med. 2022 Apr 15;41(8):1446-1461. doi: 10.1002/sim.9296. Epub 2022 Jan 4.

Abstract

Longitudinal cohorts to determine the incidence of HIV infection are logistically challenging, so researchers have sought alternative strategies. Recency test methods use biomarker profiles of HIV-infected subjects in a cross-sectional sample to infer whether they are "recently" infected and to estimate incidence in the population. Two main estimators have been used in practice: one that assumes a recency test is perfectly specific, and another that allows for false-recent results. To date, these commonly used estimators have not been rigorously studied with respect to their assumptions and statistical properties. In this article, we present a theoretical framework with which to understand these estimators and interrogate their assumptions, and perform a simulation study and data analysis to assess the performance of these estimators under realistic HIV epidemiological dynamics. We find that the snapshot estimator and the adjusted estimator perform well when their corresponding assumptions hold. When assumptions on constant incidence and recency test characteristics fail to hold, the adjusted estimator is more robust than the snapshot estimator. We conclude with recommendations for the use of these estimators in practice and a discussion of future methodological developments to improve HIV incidence estimation via recency test.

Keywords: HIV; biomarker; incidence; prevalence; recency assay.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers
  • Computer Simulation
  • Cross-Sectional Studies
  • HIV Infections* / epidemiology
  • Humans
  • Incidence

Substances

  • Biomarkers